Navigation Links
RNA Amplification Just Got Better: MessageAmp II


Compatible with GeneChip analysis

Amplify as little as 100 ng RNA in a single round

Includes the new ArrayScript engineered M-MLV RT, engineered to maximize yields of full- length cDNA

cRNA synthesis powered by MEGAscript, the best in vitro transcription technology

Consistently delivers high percent Present Calls and low 3'/5' ratios in GeneChip analysis

Gene arrays simultaneously measure the expression levels of thousands of genes in a single experiment and have become the most widely used method for assessing gene expression on a genome wide scale. The primary limitation of this technology is the requirement for large amounts of RNA for array hybridization. This is especially a problem when working with limited samples, such as small biopsies, mRNA-deficient cells and tissues, primary cell cultures, and laser capture microdissection (LCM) samples. This hurdle is usually overcome by using T7 RNA polymerase driven transcription of cDNA obtained from total RNA samples to generate sufficient amounts of amplified antisense or copy RNA (aRNA or cRNA). This amplification method is commonly referred to as the "Eberwine method" [1], "IVT method" or the "aRNA or cRNA method".

Ambion's new MessageAmp II aRNA Amplification
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
2. Simple Purification of DNA from Plasmid Minipreps, PCR Amplifications and Agarose Gels
3. Greater Amplification Specificity with New Hot Start PCR Enzyme
4. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
5. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
6. Improve Amplification Specificity with Hot Start PCR Enzyme
7. Amplification of the amoA Gene of Nitrosococcus oceani Bacteria Using Eppendorf MasterTaq
8. Amplification of Mouse cDNAs for Microarrays Using the Eppendorf MasterTaq Kit
9. Optimizing the Direct Amplification of Missing cDNA 5 Ends Using the Eppendorf Mastercycler gradient
10. Optimizing DNA Amplification Protocols using the Eppendorf Mastercycler
11. Amplification of Epstein-Barr Virus Exon C with Difficult Primers Using Eppendorf Mastercycler gradient

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: RNA Amplification Just Got Better MessageAmp

(Date:11/9/2009)...v. 9 BioMed Realty Trust...any has received commitments from lenders to incre...f credit by $65 million to an aggregate of $665 mi...acility. The weighted-average effective interest ...of September 30, 2009. The maturity date remains A...
(Date:11/9/2009)...Nov. 9 CEL-SCI Corporati...neth S. Rosenthal, Professor of Immunology and Mic...e of Medicine and Pharmacy, reported on work condu...land Clinic and CEL-SCI on CEL-SCI,s LEAPS vaccine...Cbio Vaccine: "All Things Considered" Conference i...
(Date:11/8/2009)... As global temperatures and energy costs continue ...o a sustainable future. An attractive replacemen...ished online in Genome Research ( www.genome.org... of bioethanol-producing microorganisms, uncoverin...g new technologies needed to implement production ...
(Date:11/6/2009)...., Nov. 6 BioSpecifics T...tical company developing first-in-class collagenas...sults for the third quarter ended September 30, 20...mber of this year, the FDA,s Arthritis Advisory Co..., the approval of XIAFLEX(TM) for the treatment of...
Breaking Biology Technology:BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
.... 17 National Stem,Cell Holding, Inc. (Other OTC:...n, financial information, quotations and press rel...nk Sheets., OTCIQ is a secure, web-based portal t... and services to facilitate communication with the... gather market,intelligence, and inspire better co...
...7 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: V...-II, a,confirmatory clinical trial which is design...l of the Celacade(TM) System for the treatment of ...ompany has been working diligently on the ACCLAIM-... Committee led by James B. Young,MD, Chairman, Div...
...ll Enhance Quality and Speed Image Transfer at Low...Compliance, BOSTON, Dec. 17 AG Mednet, the world...nced it has been selected by,Southwest Oncology Gr...ncer,clinical trials cooperative groups in the Uni...nd HIPAA-compliant image network. With the AG,Medn...
Other Biology Technology:National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC 2Vasogen Provides an Update on ACCLAIM-II Preparations 2Vasogen Provides an Update on ACCLAIM-II Preparations 3Vasogen Provides an Update on ACCLAIM-II Preparations 4AG Mednet to Provide Image Network for Southwest Oncology Group 2
(Date:11/5/2009)...versity have developed synthetic molecules capable...d HIV-infected cells, as well as to prostate cance...Journal of the American Chemical Society , could l...ases. , The molecules called "antibody-recruit...recruiting molecule targeting prostate cancer" (AR...
(Date:11/4/2009)...ood obesity in the United States is reaching epide...rtising on daytime and prime time television devot... about the role television plays in obesity, a stu...of Nutrition Education and Behavior examines how ...e contributor to the problem. , Researchers at t...
(Date:11/4/2009)...FirstCall/ -- Quest Diagnostics Incorporated (NYSE...ic testing, information and services, announced th... income from continuing operations rose to $192 mi...on, or $0.81 per diluted share, for the third quar...educed by a $0.03 per share charge associated with...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Queens scientists on international team discover ecologically unique changes in Arctic lake 10452 1Queens scientists on international team discover ecologically unique changes in Arctic lake 10452 20 2 second test for explosive liquids 14554 10 2 second test for explosive liquids 14554 2MDS Inc Announces Shareholder Approval of Sale of MDS Analytical Technologies 59872 1MDS Inc Announces Shareholder Approval of Sale of MDS Analytical Technologies 59872 2MDS Inc Announces Shareholder Approval of Sale of MDS Analytical Technologies 59872 3
...e sure to check out the complete report on the HI...ages. , There is new evidence that adult HIV infe...d that changes in behaviour to prevent infection—s...xual experience and fewer sexual partners—have pla...t also indicates, however, that overall trends in ...
...s ago the study of the effects of atmospheric depo...entific sphere and the term "acid rain" was coined...ecause, due to the burning of fossil fuels, the am...ere is greater than that derived from natural proc...apour and under the oxido-reduction conditions pre...
... toward developing enzymes to treat diseases such ...reatsA team of biomedical researchers from Brandei... has determined the first 3-dimensional structure ...tain bacterial infections in plants, animals and h...edings of the National Academy of Sciences. , The...
Other Biology News:2005 AIDS figures released by WHO and UNAIDS 22005 AIDS figures released by WHO and UNAIDS 32005 AIDS figures released by WHO and UNAIDS 4'Acid rain' and forest mass: Another perspective 2Scientists determine structure of enzyme that disrupts bacterial virulence 2
Mouse Anti-Human CRKRS Monoclonal Antibody, Unconjugated, Clone 3C1 from Abnova Corporation
...lyclonal antibody raised against a partial recombi... 250 a.a) partial recombinant protein with GST tag...ARDSAQAKRKYQEASKDKDRDKAKDKYVRSLWKLFAHHNRYVLGVRAAQL...REMAA Accession: BC035357 Protein Accession...
Mouse Anti-PPP4C Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human CAPG Monoclonal Antibody, Unconjugated, Clone 6D6 from Abnova Corporation
Biology Products: